{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:45:22Z","timestamp":1793907922895,"version":"4.8.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T00:00:00Z","timestamp":1686355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T00:00:00Z","timestamp":1686355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Gen \u0130la\u00e7 ve Sa\u011fl\u0131k \u00dcr\u00fcnleri A.\u015e."},{"name":"TUB\u0130TAK","award":["5180004"],"award-info":[{"award-number":["5180004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s13555-023-00939-7","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T06:01:38Z","timestamp":1686376898000},"page":"1489-1501","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety and Efficacy of a Novel Combination Cream (GN-037) in Healthy Volunteers and Patients with Plaque Psoriasis: A Phase 1 Trial"],"prefix":"10.1007","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct05428202","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Zafer","family":"Sezer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Inal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salih L.","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa M.","family":"Mazicioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedat","family":"Altug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice Y.","family":"Karasulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mine","family":"Diril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayca","family":"Mehmetoglu Al","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serhat","family":"Kozlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2681-8615","authenticated-orcid":false,"given":"Nadir","family":"Ulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,10]]},"reference":[{"issue":"3","key":"939_CR1","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1365-2133.2009.09593.x","volume":"162","author":"M Augustin","year":"2010","unstructured":"Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Sch\u00e4fer I. Epidemiology, and comorbidity of psoriasis in children. Br J Dermatol. 2010;162(3):633\u20136.","journal-title":"Br J Dermatol"},{"issue":"6","key":"939_CR2","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/bjd.12230","volume":"168","author":"K Danielsen","year":"2013","unstructured":"Danielsen K, Olsen AO, Wilsgaard T, Furberg AS. Is the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohort. Br J Dermatol. 2013;168(6):1303\u201310.","journal-title":"Br J Dermatol"},{"issue":"18","key":"939_CR3","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1056\/NEJMra041320","volume":"352","author":"MP Sch\u00f6n","year":"2005","unstructured":"Sch\u00f6n MP, Boehncke WH. Psoriasis. N Engl J Med. 2005;352(18):1899\u2013912.","journal-title":"N Engl J Med"},{"issue":"4","key":"939_CR4","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jaad.2009.05.047","volume":"65","author":"CC Jacobson","year":"2011","unstructured":"Jacobson CC, Kumar S, Kimball AB. Latitude and psoriasis prevalence. J Am Acad Dermatol. 2011;65(4):870\u20133.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"939_CR5","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/bjd.15149","volume":"176","author":"KF Hjuler","year":"2017","unstructured":"Hjuler KF, Gormsen LC, Vendelbo MH, Egeberg A, Nielsen J, Iversen L. Increased global arterial and subcutaneous adipose tissue inflammation in patients with moderate-to-severe psoriasis. Br J Dermatol. 2017;176(3):732\u201340.","journal-title":"Br J Dermatol"},{"issue":"19","key":"939_CR6","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945\u201360.","journal-title":"JAMA"},{"issue":"5","key":"939_CR7","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.3390\/ijms21051690","volume":"21","author":"M Kamata","year":"2020","unstructured":"Kamata M, Tada Y. Efficacy and safety of biologics for psoriasis and psoriatic arthritis and their impact on comorbidities: a literature review. Int J Mol Sci. 2020;21(5):1690.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"939_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/jid.1952.72","volume":"19","author":"MB Sulzberger","year":"1952","unstructured":"Sulzberger MB, Witten VH. The effect of topically applied compound F in selected dermatoses. J Invest Dermatol. 1952;19(2):101\u20132.","journal-title":"J Invest Dermatol"},{"issue":"10201","key":"939_CR9","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S0140-6736(19)31773-8","volume":"394","author":"K Reich","year":"2019","unstructured":"Reich K, Armstrong AW, Langley RG, Flavin S, Randazzo B, Li S, et al. Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial. Lancet. 2019;394(10201):831\u20139.","journal-title":"Lancet"},{"issue":"12","key":"939_CR10","first-page":"CD011535","volume":"12","author":"E Sbidian","year":"2017","unstructured":"Sbidian E, Chaimani A, Afach S, Doney L, Dressler C, Hua C, et al. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database Syst Rev. 2017;12(12):CD011535.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"939_CR11","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/bjd.18245","volume":"182","author":"NJ Korman","year":"2020","unstructured":"Korman NJ. Management of psoriasis as a systemic disease: what is the evidence? Br J Dermatol. 2020;182(4):840\u20138.","journal-title":"Br J Dermatol"},{"issue":"4","key":"939_CR12","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/bjd.19325","volume":"183","author":"SK Mahil","year":"2020","unstructured":"Mahil SK, Ezejimofor MC, Exton LS, Manounah L, Burden AD, Coates LC, et al. Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysis. Br J Dermatol. 2020;183(4):638\u201349.","journal-title":"Br J Dermatol"},{"issue":"1","key":"939_CR13","first-page":"3446174","volume":"22","author":"N Issa","year":"2023","unstructured":"Issa N, Kircik L. Supplement individual article: a reappraisal of fixed-combination halobetasol propionate and tazarotene for the treatment of psoriasis: biological underpinnings, therapeutic mechanisms, and economic considerations. J Drugs Dermatol. 2023;22(1):3446174\u201334461710.","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"939_CR14","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/1744666X.2020.1776116","volume":"16","author":"M Megna","year":"2020","unstructured":"Megna M, Cinelli E, Camela E, Fabbrocini G. Calcipotriol\/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data. Expert Rev Clin Immunol. 2020;16(6):599\u2013620.","journal-title":"Expert Rev Clin Immunol"},{"issue":"5","key":"939_CR15","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/bjd.12276","volume":"168","author":"EJ Samarasekera","year":"2013","unstructured":"Samarasekera EJ, Sawyer L, Wonderling D, Tucker R, Smith CH. Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses. Br J Dermatol. 2013;168(5):954\u201367.","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"939_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/jdv.17053","volume":"35","author":"M Lebwohl","year":"2021","unstructured":"Lebwohl M, Tha\u00e7i D, Warren RB. Addressing challenges associated with long-term topical treatment and benefits of proactive management in patients with psoriasis. J Eur Acad Dermatol Venereol. 2021;35(Suppl 1):35\u201341.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"939_CR17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jaad.2018.03.040","volume":"79","author":"LS Gold","year":"2018","unstructured":"Gold LS, Lebwohl MG, Sugarman JL, et al. Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: results of 2 phase 3 randomized controlled trials. J Am Acad Dermatol. 2018;79(2):287\u201393.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"939_CR18","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1080\/1744666X.2022.2110071","volume":"18","author":"M Chung","year":"2022","unstructured":"Chung M, Yeroushalmi S, Hakimi M, Bartholomew E, Liao W, Bhutani T. A critical review of halobetasol propionate foam (0.05%) as a treatment option for adolescent plaque psoriasis. Expert Rev Clin Immunol. 2022;18(10):997\u20131003.","journal-title":"Expert Rev Clin Immunol"},{"issue":"8","key":"939_CR19","first-page":"790","volume":"18","author":"N Bhatia","year":"2019","unstructured":"Bhatia N, Stein Gold L, Kircik LH, Schreiber R. Two multicenter, randomized, double-blind, parallel group comparison studies of a novel foam formulation of halobetasol propionate, 0.05% vs its vehicle in adult subjects with plaque psoriasis. J Drugs Dermatol. 2019;18(8):790\u20136.","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"939_CR20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4103\/ijp.IJP_728_19","volume":"53","author":"R Jhaj","year":"2021","unstructured":"Jhaj R, Asati DP, Chaudhary D, Sadasivam B. Topical steroid containing combinations: burden of adverse effects and why the recent regulatory action may not be enough. Indian J Pharmacol. 2021;53(5):371\u20136.","journal-title":"Indian J Pharmacol"},{"issue":"3","key":"939_CR21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","volume":"140","author":"JE Hawkes","year":"2017","unstructured":"Hawkes JE, Chan TC, Krueger JG. Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol. 2017;140(3):645\u201353.","journal-title":"J Allergy Clin Immunol"},{"key":"939_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"MA Lowes","year":"2014","unstructured":"Lowes MA, Suarez-Farinas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;32:227\u201355.","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"939_CR23","first-page":"643","volume":"16","author":"M Nakamura","year":"2017","unstructured":"Nakamura M, Abrouk M, Zhu H, Farahnik B, Koo J, Bhutani T. Update on the systemic risks of superpotent topical steroids. J Drugs Dermatol. 2017;16(7):643\u20138.","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"939_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/09546634.2018.1523362","volume":"30","author":"FA Kerdel","year":"2019","unstructured":"Kerdel FA, Draelos ZD, Tyring SK, Lin T, Pillai R. A phase 2, multicenter, double-blind, randomized, vehicle-controlled clinical study to compare the safety and efficacy of a halobetasol propionate 0.01% lotion and halobetasol propionate 0.05% cream in the treatment of plaque psoriasis. J Dermatolog Treat. 2019;30(4):333\u20139.","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"939_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0190-9622(08)82011-7","volume":"29","author":"P Walsh","year":"1993","unstructured":"Walsh P, Aeling JL, Huff L, Weston WL. Hypothalamus-pituitary-adrenal axis suppression by superpotent topical steroids. J Am Acad Dermatol. 1993;29(3):501\u20133.","journal-title":"J Am Acad Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-00939-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-023-00939-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-00939-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T01:57:54Z","timestamp":1729562274000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-023-00939-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,10]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["939"],"URL":"https:\/\/doi.org\/10.1007\/s13555-023-00939-7","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,10]]},"assertion":[{"value":"13 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}